支持新药向发现的证据的时间趋势
Maria J Falaguera1,2, Ellen M McDonagh3,4,5, David Ochoa3,4
1Open Targets, Wellcome Genome Campus, Hinxton, UK. mariaf@ebi.ac.uk.
Nature communications
|December 7, 2025
概括
约有20%的FDA批准的新药针对新的机制,推动创新. 支持这些新药标的证据越来越多地出现在批准之前,有助于早期识别.
科学领域:
- 生物医学研究的研究.
- 药物发现 药物发现
- 药理学 药理学是指药理学的学科.
背景情况:
- 新型行动机制 (MOA) 目标对于药物发现的创新至关重要,尽管风险更高.
- 开放目标平台是确定潜在毒品目标的已有资源.
- 每年大约有20%的FDA批准的药物针对人类的新型MOA.
研究的目的:
- 通过时间印和目标新度指标来增强开放目标平台.
- 分析过去二十年新药标批准的趋势.
- 评估生物医学证据与新目标药物批准之间的时间关系.
主要方法:
- 在数以百万计的生物医学数据点中实施了全面的时间标记.
- 引入了针对疾病背景的目标新度指标.
- 进行了对过去20年新药标批准的回顾性分析.
主要成果:
- 开放目标平台的功能得到了扩展,并增加了用于新目标发现的新功能.
- 在2015年左右,在新药标批准方面观察到一个显著的趋势转变.
- 在药物批准之前,越来越多地记录了支持生物医学证据 (遗传学,文学,表达,途径).
结论:
- 时间标记和新度量提高了新目标的识别.
- 与批准相比,证据生成的时间对于评估新目标至关重要.
- 这些发现为优化未来药物标选择策略提供了洞察力.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Patch Clamp
6.3K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
6.3K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K


